Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)

China flag China · Delayed Price · Currency is CNY
7.69
-0.14 (-1.79%)
At close: Mar 9, 2026
19.41%
Market Cap 13.01B
Revenue (ttm) 16.62B
Net Income (ttm) 1.28B
Shares Out 1.66B
EPS (ttm) 0.77
PE Ratio 10.15
Forward PE 10.30
Dividend 0.38 (4.85%)
Ex-Dividend Date Jun 23, 2025
Volume 35,696,679
Average Volume 34,934,653
Open 7.79
Previous Close 7.83
Day's Range 7.66 - 7.79
52-Week Range 5.91 - 8.55
Beta 0.33
RSI 58.87
Earnings Date Mar 17, 2026

About SHA:600866

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroyi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1964
Employees 9,293
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600866
Full Company Profile

Financial Performance

In 2024, SHA:600866's revenue was 17.33 billion, a decrease of -0.23% compared to the previous year's 17.37 billion. Earnings were 943.15 million, an increase of 39.12%.

Financial Statements

News

There is no news available yet.